Global Strategy Development and Implementation Assignment 2022

Global Strategy Development and
Implementation
i

Table of Contents
Introduction:....................................................................................................................................1
Porter Diamond................................................................................................................................2
The Internationalising Strategy........................................................................................................5
Country Analysis (Denmark)...........................................................................................................7
PESL framework.........................................................................................................................7
Porters 5 forces analysis..................................................................................................................9
Mode of Entry................................................................................................................................11
Problems in Denmark....................................................................................................................13
Solutions to the problems..............................................................................................................14
Conclusion.....................................................................................................................................15
References......................................................................................................................................16
ii

Introduction:
GlaxoSmithKline (GSK) is a global health firm that develops, manufactures, and markets
pharmaceutical medications, vaccines, and other healthcare products. It is the sixth-largest
pharmaceutical firm in the world. It was customary in 1715, but it did not exist in its current
form until 2000, when four large pharmaceutical businesses merged. GlaxoSmithKline is a well-
known pharmaceutical company in the world. The international corporation's headquarters are in
London, United Kingdom. The corporation made 34.1 billion British pounds in 2021, virtually
precisely the same as the previous year. It has a total of 94,000 employees all around the world.
With commercial activities in more than 150 countries, 87 manufacture amenities in 36
countries, and extensive exploration and development facilities in China, the United Kingdom,
Spain, the United States, Belgium, and it has a significant global footprint (Tailor, 2022). GSK
wants to expand its business operation to Denmark. The report consists of Porter's five forces
analysis and how GSK internationalises its business using various entry strategies and solves
Denmark's diverse cultural, process, and structural barriers.
1

Porter Diamond
The Diamond Model, also derived from the theory of domestic competitive benefit of
Enterprises, is a strategic tool used by firms to decide and achieve the modest benefit essential
for global sustainability and diversification.
Figure 1: Poter's Diamond of GlaxoSmithKline (GSK)
Source: (Bradley, 2016)
Factor conditions
Factor conditions are attributes that provide a competitive benefit to the sector and its businesses
(Goyal, 2021). Despite natural assets, factor conditions are frequently spawned by the
authorities. For example, GlaxoSmithKline plc possesses the following fundamental conditions:
significant genuine investments in the home nation, good equity strategy and capital leverage,
highly qualified human resources, cutting-edge technology, and world-class architecture.
Related and supporting industries
The occurrence of associate and opposing players in the business delivers constructive pressure
and inspires the mantra to business troupes to outrival and expand through modernisation and
globalisation. For GlaxoSmithKline plc, the associate and correlated firms have also been mainly
2